A lot of back and forth these last few weeks about

A lot of back and forth these last few weeks about what could be going on at CYDY headquarters. We're all restless, waiting for news, but the one thing that keeps me positive, and keeps me averaging down when I can, is the the fact that the doctors and scientific advisors most familiar with Leronlimab are still with the company. The ones that know the most about the drug, that have used it in trials, and even personally been treated with it, like Recknor, have come on board and stayed there, even through these tumultuous times.

Long and strong CYDY